SCHEMBL1492838

SCHEMBL1492838

CCCCOc1cccc(NC(=O)Nc2ccc(-c3ccnc(C)c3)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PORCN Q9H237 2/20 0.55
PSEN1 P49768 10/20 0.54
PSEN2 P49810 10/20 0.54
APH1B Q8WW43 10/20 0.54
NCSTN Q92542 10/20 0.54
APH1A Q96BI3 10/20 0.54
PSENEN Q9NZ42 10/20 0.54
THRB P10828 1/20 0.54
WNT3A P56704 1/20 0.50
FAAH O00519 1/20 0.50
NR1H4 Q96RI1 2/20 0.49
TP53 P04637 1/20 0.48
TSHR P16473 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492873 0.95 PSEN1 (0.54) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492766 0.90 PSEN1 (0.56) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492843 0.85 NPC1 (0.64) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492696 0.84 CNR1 (0.60) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492839 0.84 PORCN (0.61) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL27809666 0.82 PSEN1 (0.61) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492858 0.81 CNR1 (0.65) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1781477 0.81 PSEN1 (0.61) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492870 0.81 PSEN1 (0.67) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1493028 0.80 PSEN1 (0.68) PORCNPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PORCN 3166/4885PSEN1 3/4885PSEN2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.